By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website –
Check out our openings –

Key Statistics

Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN


Sanofi US 


Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 

Company News
Regeneron (REGN) And Sanofi (SNY) Announce Approval Of Kevzara (Sarilumab) To Treat Adult Patients With Moderately To Severely Active Rheumatoid Arthritis In The European Union 6/27/2017 7:05:10 AM
Regeneron (REGN) Details Royalty Agreement With Novartis AG (NVS) For Canakinumab (ACZ885) 6/22/2017 7:47:17 AM
Life Sciences Professionals Name Top 30 Ideal Employers 6/15/2017 10:43:10 AM
Regeneron (REGN) And Sanofi (SNY) Announce Positive Results From First Dedicated Studies Evaluating Praluent (Alirocumab) In Individuals With Diabetes And Hypercholesterolemia 6/12/2017 7:22:37 AM
How Pharma Giant Regeneron (REGN) Makes Most Of Its Cash 6/1/2017 6:47:45 AM
Regeneron (REGN) Announces ANGPTL3/Evinacumab Publication In The New England Journal of Medicine And Positive Phase ll Data In People With HoFH 5/25/2017 6:53:51 AM
ICON And Regeneron (REGN) Win Best Partnership In Clinical Research Award From PharmaTimes 5/24/2017 7:47:13 AM
Market Just Got More Crowded as Regeneron (REGN), Sanofi (SNY)'s New RA Drug Wins FDA Approval 5/23/2017 6:23:55 AM
Regeneron (REGN) And SillaJen Announce Immuno-Oncology Clinical Study Agreement For Combination Treatment In Kidney Cancer 5/8/2017 6:59:42 AM
Regeneron (REGN) And Inovio Pharma (INO) Enter Immuno-Oncology Clinical Study Agreement For Glioblastoma Combination Therapy 5/8/2017 6:29:37 AM